Other products from "MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT"
No Primary DI Version or Model Catalog Number Device Description Product Code Product Code Name Device Class Brand Name
1 04250971421625 T62CB03-5-1 6.2CB03 Synthacer® 600 Ceraball®, HA, diameter 3 mm, 5 ml MQV Filler, Bone Void, Calcium Compound 2 Synthacer
2 04250971421618 T62CB03-2-1 6.2CB03 Synthacer® 600 Ceraball®, HA, diameter 3 mm, 2 ml MQV Filler, Bone Void, Calcium Compound 2 Synthacer
3 04250971421601 T62CB0406-30-1 6.2CB0406 Synthacer® 600 Ceraball®, HA, mixture with diameters 4 mm and 6 mm, 30 ml MQV Filler, Bone Void, Calcium Compound 2 Synthacer
4 04250971421595 T62CB0406-20-1 6.2CB0406 Synthacer® 600 Ceraball®, HA, mixture with diameters 4 mm and 6 mm, 20 ml MQV Filler, Bone Void, Calcium Compound 2 Synthacer
5 04250971421656 T61CB15-3-1 6.1CB1.5 Synthacer® 300 Ceraball®, HA, diameter 1.5 mm, 3 ml MQV Filler, Bone Void, Calcium Compound 2 Synthacer
6 04250971421649 T61CB15-2-1 6.1CB1.5 Synthacer® 300 Ceraball®, HA, diameter 1.5 mm, 2 ml MQV Filler, Bone Void, Calcium Compound 2 Synthacer
7 04250971421632 T61CB15-1-1 6.1CB1.5 Synthacer® 300 Ceraball®, HA, diameter 1.5 mm, 1 ml MQV Filler, Bone Void, Calcium Compound 2 Synthacer
8 04250971421588 T62CB0406-10-1 6.2CB0406 Synthacer® 600 Ceraball®, HA, mixture with diameters 4 mm and 6 mm, 10 ml MQV Filler, Bone Void, Calcium Compound 2 Synthacer
9 04250971421571 T62CB06-10-1 6.2CB06 Synthacer® 600 Ceraball®, HA, diameter 6 mm, 10 ml MQV Filler, Bone Void, Calcium Compound 2 Synthacer
10 04250971421564 T62CB04-10-1 6.2CB04 Synthacer® 600 Ceraball®, HA, diameter 4 mm, 10 ml MQV Filler, Bone Void, Calcium Compound 2 Synthacer
11 04250971420161 T63G03-2-1 6.3G03 Synthacer® 1000 granules, HA, particle size 2.6 - 4.8 mm, 2 ml MQV Filler, Bone Void, Calcium Compound 2 Synthacer
12 04250971420154 T63G03-1-1 6.3G03 Synthacer® 1000 granules, HA, particle size 2.6 - 4.8 mm, 1 ml MQV Filler, Bone Void, Calcium Compound 2 Synthacer
13 04250971420147 T63G02-2-1 6.3G02 Synthacer® 1000 granules, HA, particle size 1.0 - 2.5 mm, 2 ml MQV Filler, Bone Void, Calcium Compound 2 Synthacer
14 04250971420130 T63G02-1-1 6.3G02 Synthacer® 1000 granules, HA, particle size 1.0 - 2.5 mm, 1 ml MQV Filler, Bone Void, Calcium Compound 2 Synthacer
15 04250971420123 T63G01-2-1 6.3G01 Synthacer® 1000 powder, HA, particle size 0.1 - 0.9 mm, 2 ml MQV Filler, Bone Void, Calcium Compound 2 Synthacer
16 04250971420116 T63G01-1-1 6.3G01 Synthacer® 1000 powder, HA, particle size 0.1 - 0.9 mm, 1 ml MQV Filler, Bone Void, Calcium Compound 2 Synthacer
17 04250971420109 T61G03-2-1 6.1G03 Synthacer® 300 granules, HA, particle size 2.6 - 4.8 mm, 2 ml MQV Filler, Bone Void, Calcium Compound 2 Synthacer
18 04250971420093 T61G03-1-1 6.1G03 Synthacer® 300 granules, HA, particle size 2.6 - 4.8 mm, 1 ml MQV Filler, Bone Void, Calcium Compound 2 Synthacer
19 04250971420086 T61G02-2-1 6.1G02 Synthacer® 300 granules, HA, particle size 1.0 - 2.5 mm, 2 ml MQV Filler, Bone Void, Calcium Compound 2 Synthacer
20 04250971420079 T61G02-1-1 6.1G02 Synthacer® 300 granules, HA, particle size 1.0 - 2.5 mm, 1 ml MQV Filler, Bone Void, Calcium Compound 2 Synthacer
21 04250971420062 T61G01-2-1 6.1G01 Synthacer® 300 powder, HA, particle size 0.1 - 0.9 mm, 2 ml MQV Filler, Bone Void, Calcium Compound 2 Synthacer
22 04250971420055 T61G01-1-1 6.1G01 Synthacer® 300 powder, HA, particle size 0.1 - 0.9 mm, 1 ml MQV Filler, Bone Void, Calcium Compound 2 Synthacer
23 04250971420048 T62G03-2-1 6.2G03 Synthacer® 600 granules, HA, particle size 2.6 - 4.8 mm, 2 ml MQV Filler, Bone Void, Calcium Compound 2 Synthacer
24 04250971420031 T62G03-1-1 6.2G03 Synthacer® 600 granules, HA, particle size 2.6 - 4.8 mm, 1 ml MQV Filler, Bone Void, Calcium Compound 2 Synthacer
25 04250971420024 T62G02-2-1 6.2G02 Synthacer® 600 granules, HA, particle size 1.0 - 2.5 mm, 2 ml MQV Filler, Bone Void, Calcium Compound 2 Synthacer
26 04250971420017 T62G02-1-1 6.2G02 Synthacer® 600 granules, HA, particle size 1.0 - 2.5 mm, 1 ml MQV Filler, Bone Void, Calcium Compound 2 Synthacer
27 04250971420000 T62G01-2-1 6.2G01 Synthacer® 600 powder, HA, particle size 0.1 - 0.9 mm, 2 ml MQV Filler, Bone Void, Calcium Compound 2 Synthacer
28 04250971419998 T62G01-1-1 6.2G01 Synthacer® 600 powder, HA, particle size 0.1 - 0.9 mm, 1 ml MQV Filler, Bone Void, Calcium Compound 2 Synthacer
29 04250971403997 T6N3CB03-1 6.N3CB03 Synthacer® 1000 Ceraball®, "negative", HA, diameter 3 mm MQV Filler, Bone Void, Calcium Compound 2 Synthacer
30 04250971403980 T6N3CB0406-1 6.N3CB0406 Synthacer® 1000 Ceraball®, "negative", HA, mixture with diameters 4 mm and 6 mm MQV Filler, Bone Void, Calcium Compound 2 Synthacer
31 04250971403973 T6N3CB06-1 6.N3CB06 Synthacer® 1000 Ceraball®, "negative", HA, diameter 6 mm MQV Filler, Bone Void, Calcium Compound 2 Synthacer
32 04250971403966 T6N3CB04-1 6.N3CB04 Synthacer® 1000 Ceraball®, "negative", HA, diameter 4 mm MQV Filler, Bone Void, Calcium Compound 2 Synthacer
33 04250971403812 T6N3MM10-1 6.N3MM10 Synthacer® 1000 block, "negative", HA, 10 x 10 x 15 mm MQV Filler, Bone Void, Calcium Compound 2 Synthacer
34 04250971403959 T6N3GR03-1 6.N3GR03 Synthacer® 1000 rounded granules Ceround®, "negative", HA, particle size 2.6 - 4.8 mm MQV Filler, Bone Void, Calcium Compound 2 Synthacer
35 04250971403942 T6N3G03-1 6.N3G03 Synthacer® 1000 granules, "negative", HA, particle size 2.6 - 4.8 mm MQV Filler, Bone Void, Calcium Compound 2 Synthacer
36 04250971403935 T6N3GR02-1 6.N3GR02 Synthacer® 1000 rounded granules Ceround®, "negative", HA, particle size 1.0 - 2.5 mm MQV Filler, Bone Void, Calcium Compound 2 Synthacer
37 04250971403928 T6N3G02-1 6.N3G02 Synthacer® 1000 granules, "negative", HA, particle size 1.0 - 2.5 mm MQV Filler, Bone Void, Calcium Compound 2 Synthacer
38 04250971403911 T6N3G01-1 6.N3G01 Synthacer® 1000 powder, "negative", HA, particle size 0.1 - 0.9 mm MQV Filler, Bone Void, Calcium Compound 2 Synthacer
39 04250971403867 T6N3K13-1 6.N3K13 Synthacer® 1000 wedge, "negative", HA, 30 x 22 x 13 mm MQV Filler, Bone Void, Calcium Compound 2 Synthacer
40 04250971403850 T6N3K11-1 6.N3K11 Synthacer® 1000 wedge, "negative", HA, 30 x 22 x 11 mm MQV Filler, Bone Void, Calcium Compound 2 Synthacer
41 04250971403843 T6N3K9-1 6.N3K9 Synthacer® 1000 wedge, "negative", HA, 30 x 22 x 9 mm MQV Filler, Bone Void, Calcium Compound 2 Synthacer
42 04250971403829 T6N3MM20-1 6.N3MM20 Synthacer® 1000 block, "negative", HA, 20 x 20 x 15 mm MQV Filler, Bone Void, Calcium Compound 2 Synthacer
43 04250971403805 T6N3MM05-1 6.N3MM05 Synthacer® 1000 block, "negative", HA, 5 x 5 x 15 mm MQV Filler, Bone Void, Calcium Compound 2 Synthacer
44 04250971403775 T6N317TMO-1 6.N317TMO Synthacer® 1000 cylinder, "negative", HA, size 17, diameter 21.15 mm, length 25 Synthacer® 1000 cylinder, "negative", HA, size 17, diameter 21.15 mm, length 25 mm, without lid MQV Filler, Bone Void, Calcium Compound 2 Synthacer
45 04250971403768 T6N317TMC-1 6.N317TMC Synthacer® 1000 cylinder, "negative", HA, size 17, diameter 21.15 mm, length 25 Synthacer® 1000 cylinder, "negative", HA, size 17, diameter 21.15 mm, length 25 mm, with lid MQV Filler, Bone Void, Calcium Compound 2 Synthacer
46 04250971403751 T6N316TMO-1 6.N316TMO Synthacer® 1000 cylinder, "negative", HA, size 16, diameter 19.95 mm, length 25 Synthacer® 1000 cylinder, "negative", HA, size 16, diameter 19.95 mm, length 25 mm, without lid MQV Filler, Bone Void, Calcium Compound 2 Synthacer
47 04250971403744 T6N316TMC-1 6.N316TMC Synthacer® 1000 cylinder, "negative", HA, size 16, diameter 19.95 mm, length 25 Synthacer® 1000 cylinder, "negative", HA, size 16, diameter 19.95 mm, length 25 mm, with lid MQV Filler, Bone Void, Calcium Compound 2 Synthacer
48 04250971403737 T6N315TMO-1 6.N315TMO Synthacer® 1000 cylinder, "negative", HA, size 15, diameter 18.75 mm, length 25 Synthacer® 1000 cylinder, "negative", HA, size 15, diameter 18.75 mm, length 25 mm, without lid MQV Filler, Bone Void, Calcium Compound 2 Synthacer
49 04250971403720 T6N315TMC-1 6.N315TMC Synthacer® 1000 cylinder, "negative", HA, size 15, diameter 18.75 mm, length 25 Synthacer® 1000 cylinder, "negative", HA, size 15, diameter 18.75 mm, length 25 mm, with lid MQV Filler, Bone Void, Calcium Compound 2 Synthacer
50 04250971403713 T6N314TMO-1 6.N314TMO Synthacer® 1000 cylinder, "negative", HA, size 14, diameter 17.55 mm, length 25 Synthacer® 1000 cylinder, "negative", HA, size 14, diameter 17.55 mm, length 25 mm, without lid MQV Filler, Bone Void, Calcium Compound 2 Synthacer
Other products with the same Product Code "MQV"
No Primary DI Version or Model Catalog Number Device Description Brand Name Organization Name
1 00817771028764 Solum IV - 20cc 1201-0200 Solum IV Bone Void Filler CELLING BIOSCIENCES
2 00817771028757 Solum IV - 10cc 1201-0100 Solum IV Bone Void Filler CELLING BIOSCIENCES
3 00817771028740 Solum IV - 5cc 1201-0050 Solum IV Bone Void Filler CELLING BIOSCIENCES
4 00817771028733 Solum IV - 2cc 1201-0020 Solum IV Bone Void Filler CELLING BIOSCIENCES
5 00817771028726 Solum IV - 1cc 1201-0010 Solum IV Bone Void Filler CELLING BIOSCIENCES
6 00817371020632 Solum Flow - 5cc 1206-0050 Solum Flow CELLING BIOSCIENCES
7 00817371020625 Solum Flow - 2cc 1206-0020 Solum Flow CELLING BIOSCIENCES
8 00817337000074 6000041 Tactoset is a synthetic, injectable, settable osteoconductive calcium phosphate Tactoset is a synthetic, injectable, settable osteoconductive calcium phosphate bone graft substitute material. Tactoset ANIKA THERAPEUTICS, INC.
9 00817337000050 6000041 SCS 17-01 is a synthetic, injectable, settable osteoconductive calcium phosphate SCS 17-01 is a synthetic, injectable, settable osteoconductive calcium phosphate bone graft substitute material. SCS 17-01 ANIKA THERAPEUTICS, INC.
10 00816986020518 200X25X8 MM, 40 CC SGFS-040 SIGNAFUSE Bioactive Bone Graft is a bioactive bone graft substitute comprising b SIGNAFUSE Bioactive Bone Graft is a bioactive bone graft substitute comprising biphasic mineral granules and 45S5 bioactive glass suspended in a porous type I collagen matrix. The device is provided sterile and is to be combined with autologous bone marrow aspirate prior to use to facilitate packing into bony defects. The device provides an osteoconductive scaffold that resorbs and guides host bone regeneration during the healing process. SIGNAFUSE Bioactive Bone Graft BIOVENTUS LLC
11 00816986020501 100X25X8 MM, 20 CC SGFS-020 SIGNAFUSE Bioactive Bone Graft is a bioactive bone graft substitute comprising b SIGNAFUSE Bioactive Bone Graft is a bioactive bone graft substitute comprising biphasic mineral granules and 45S5 bioactive glass suspended in a porous type I collagen matrix. The device is provided sterile and is to be combined with autologous bone marrow aspirate prior to use to facilitate packing into bony defects. The device provides an osteoconductive scaffold that resorbs and guides host bone regeneration during the healing process. SIGNAFUSE Bioactive Bone Graft BIOVENTUS LLC
12 00816986020495 50X25X8 MM, 10 CC SGFS-010 SIGNAFUSE Bioactive Bone Graft is a bioactive bone graft substitute comprising b SIGNAFUSE Bioactive Bone Graft is a bioactive bone graft substitute comprising biphasic mineral granules and 45S5 bioactive glass suspended in a porous type I collagen matrix. The device is provided sterile and is to be combined with autologous bone marrow aspirate prior to use to facilitate packing into bony defects. The device provides an osteoconductive scaffold that resorbs and guides host bone regeneration during the healing process. SIGNAFUSE Bioactive Bone Graft BIOVENTUS LLC
13 00816986020488 25X25X8 MM, 5 CC SGFS-005 SIGNAFUSE Bioactive Bone Graft is a bioactive bone graft substitute comprising b SIGNAFUSE Bioactive Bone Graft is a bioactive bone graft substitute comprising biphasic mineral granules and 45S5 bioactive glass suspended in a porous type I collagen matrix. The device is provided sterile and is to be combined with autologous bone marrow aspirate prior to use to facilitate packing into bony defects. The device provides an osteoconductive scaffold that resorbs and guides host bone regeneration during the healing process. SIGNAFUSE Bioactive Bone Graft BIOVENTUS LLC
14 00816986020150 15g MSBG1500 Bioactive Bone Graft Putty UNITE Bioactive Bone Graft BIOVENTUS LLC
15 00816986020143 7.5g MSBG0750 Bioactive Bone Graft Putty UNITE Bioactive Bone Graft BIOVENTUS LLC
16 00816986020136 3.75g MSBG0375 Bioactive Bone Graft Putty UNITE Bioactive Bone Graft BIOVENTUS LLC
17 00816986020129 18cc OMP-18 OSTEOMATRIX+ is a bone graft substitute comprising biphasic mineral granules sus OSTEOMATRIX+ is a bone graft substitute comprising biphasic mineral granules suspended in a porous type I collagen matrix. The device is provided sterile and is to be combined with autologous bone marrow aspirate prior to use to facilitate packing into bony defects. The device provides an osteoconductive scaffold that resorbs and guides host bone regeneration during the healing process. OSTEOMATRIX+ BIOVENTUS LLC
18 00816986020112 9cc OMP-09 OSTEOMATRIX+ is a bone graft substitute comprising biphasic mineral granules sus OSTEOMATRIX+ is a bone graft substitute comprising biphasic mineral granules suspended in a porous type I collagen matrix. The device is provided sterile and is to be combined with autologous bone marrow aspirate prior to use to facilitate packing into bony defects. The device provides an osteoconductive scaffold that resorbs and guides host bone regeneration during the healing process. OSTEOMATRIX+ BIOVENTUS LLC
19 00816986020105 15g OF003 Bioactive Bone Graft Putty OSTEOFUSE BIOVENTUS LLC
20 00816986020099 7.5g OF002 Bioactive Bone Graft Putty OSTEOFUSE BIOVENTUS LLC
21 00816986020082 3.75g OF001 Bioactive Bone Graft Putty is a synthetic bone void filler comprised of a mixtur Bioactive Bone Graft Putty is a synthetic bone void filler comprised of a mixture of calcium phosphate granules (CaP) and (45S5) bioactive glass granules suspended in a resorbable alkyleneoxide polymer (AOP) carrier that facilitates handling and delivery of the granule components. The device is supplied as putty, pre-loaded in a syringe applicator and packaged in a sterile barrier foil pouch. The device is provided sterile, for single use, in a variety of sizes. OSTEOFUSE BIOVENTUS LLC
22 00816986020037 IFBG100 IFBG100 INTERFACE is a synthetic bioactive bone graft for use in the repair of osseous d INTERFACE is a synthetic bioactive bone graft for use in the repair of osseous defects. It is supplied as irregular synthetic granules of bioactive glass (45S5 Bioglass), sized from 200 microns to 420 microns. When implanted in living tissue, the material undergoes a time dependent surface modification. The surface reaction results in the formation of a calcium phosphate layer, which is equivalent in composition and structure to the hydroxyapatite found in bone mineral. The biological apatite layer of the granules provides an osteoconductive scaffold for the generation of new osseous tissue. New bone infiltrates around the granules allowing the repair of the defect as the granules are absorbed. INTERFACE BIOVENTUS LLC
23 00816986020020 3.75g SGF-037 Bioactive Bone Graft Putty is a synthetic bone void filler comprised of a mixtur Bioactive Bone Graft Putty is a synthetic bone void filler comprised of a mixture of calcium phosphate granules (CaP) and (45S5) bioactive glass granules suspended in a resorbable alkyleneoxide polymer (AOP) carrier that facilitates handling and delivery of the granule components. The device is supplied as putty, pre-loaded in a syringe applicator and packaged in a sterile barrier foil pouch. The device is provided sterile, for single use, in a variety of sizes. SIGNAFUSE BIOVENTUS LLC
24 00816986020013 7.5g SGF-075 Bioactive Bone Graft Putty is a synthetic bone void filler comprised of a mixtur Bioactive Bone Graft Putty is a synthetic bone void filler comprised of a mixture of calcium phosphate granules (CaP) and (45S5) bioactive glass granules suspended in a resorbable alkyleneoxide polymer (AOP) carrier that facilitates handling and delivery of the granule components. The device is supplied as putty, pre-loaded in a syringe applicator and packaged in a sterile barrier foil pouch. The device is provided sterile, for single use, in a variety of sizes. SIGNAFUSE BIOVENTUS LLC
25 00816986020006 15g SGF-150 Bioactive Bone Graft Putty is a synthetic bone void filler comprised of a mixtur Bioactive Bone Graft Putty is a synthetic bone void filler comprised of a mixture of calcium phosphate granules (CaP) and (45S5) bioactive glass granules suspended in a resorbable alkyleneoxide polymer (AOP) carrier that facilitates handling and delivery of the granule components. The device is supplied as putty, pre-loaded in a syringe applicator and packaged in a sterile barrier foil pouch. The device is provided sterile, for single use, in a variety of sizes. SIGNAFUSE BIOVENTUS LLC
26 00816125022229 RGT-50X25-05 RGT-50X25-05 R-GENIN is a bone void filler consisting of purified bovine collagen, hydroxyapa R-GENIN is a bone void filler consisting of purified bovine collagen, hydroxyapatite, tri-calcium phosphate, and demineralized bone matrix (DBM). The collagen component is biocompatible. After it is implanted, it resorbs and is later replaced by natural bone.R-GENIN is indicated for use in bony voids or gaps that are not intrinsic to the stability of the bony structure. The product should be gently packed into bony voids or gaps of the skeletal system (i.e., the extremities, posterolateral spine, and pelvis). These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. The product provides a bone void filler that resorbs and is replaced by the growth of new bone during the healing process. The bone graft can be mixed with autogenous blood prior to use at the physician's discretion. R-GENIN Strip BERKELEY ADVANCED BIOMATERIALS, LLC
27 00816125023868 ARM-TCP-BA-12 ARM-TCP-BA-12 HA-TCP-Bioglass Sponge is a bone void filler consisting of a collagen matrix min HA-TCP-Bioglass Sponge is a bone void filler consisting of a collagen matrix mineralized with hydroxyapatite (HA) – tri-calcium phosphate (TCP) granules and 45S5 bioactive glass granules. The bovine fibrillar collagen component is biocompatible and the 45S5 glass particles are bioactive.HA-TCP-Bioglass Sponge is indicated for use in bony voids or gaps of the skeletal system (i.e. extremities, pelvis and posterolateral spine). These osseous defects are surgically created or result from traumatic injury to the bone and are not intrinsic to the stability of the bony structure. The graft resorbs and is replaced by the growth of new bone during the healing process. HA-TCP-Bioglass Sponge must be used with autogenous bone marrow aspirate and autograft in the posterolateral spine. HA-TCP-Bioglass Sponge BERKELEY ADVANCED BIOMATERIALS, LLC
28 00816125023851 ARM-TCP-10 ARM-TCP-10 HA-TCP Sponge is a sterile bone graft composed of purified fibrillar Type I coll HA-TCP Sponge is a sterile bone graft composed of purified fibrillar Type I collagen and Bi-Ostetic (60% hydroxyapatite - 40% tricalcium phosphate) resorbable granules. This device is safe and has excellent biocompatibility. After it is implanted, the graft resorbs and is later replaced by natural bone.HA-TCP Sponge is indicated for use in bony voids or gaps that are not intrinsic to the stability of the bony structure. The product should be gently packed into bony voids or gaps of the skeletal system (i.e., the extremities, posterolateral spine and pelvis). These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. The product provides a bone void filler that resorbs and is replaced by the growth of new bone during the healing process. In weight bearing situations, the graft is to be used in conjunction with internal or external fixation devices. The fracture defect treated should not exceed 30 ml. HA-TCP Sponge BERKELEY ADVANCED BIOMATERIALS, LLC
29 00816125023844 BF-10P BF-10P Bi-Ostetic Foam Putty is a sterile bone graft composed of purified fibrillar Typ Bi-Ostetic Foam Putty is a sterile bone graft composed of purified fibrillar Type I collagen and Bi-Ostetic (60% hydroxyapatite - 40% tricalcium phosphate) resorbable granules. This device is safe and has excellent biocompatibility. After it is implanted, the graft resorbs and is later replaced by natural bone.Bi-Ostetic Foam Putty is indicated for use in bony voids or gaps that are not intrinsic to the stability of the bony structure. The product should be gently packed into bony voids or gaps of the skeletal system (i.e., the extremities, posterolateral spine and pelvis). These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. The product provides a bone void filler that resorbs and is replaced by the growth of new bone during the healing process. In weight bearing situations, the graft is to be used in conjunction with internal or external fixation devices. The fracture defect treated should not exceed 30 ml. Bi-Ostetic Foam Putty BERKELEY ADVANCED BIOMATERIALS, LLC
30 00816125023837 BF-05P BF-05P Bi-Ostetic Foam Putty is a sterile bone graft composed of purified fibrillar Typ Bi-Ostetic Foam Putty is a sterile bone graft composed of purified fibrillar Type I collagen and Bi-Ostetic (60% hydroxyapatite - 40% tricalcium phosphate) resorbable granules. This device is safe and has excellent biocompatibility. After it is implanted, the graft resorbs and is later replaced by natural bone.Bi-Ostetic Foam Putty is indicated for use in bony voids or gaps that are not intrinsic to the stability of the bony structure. The product should be gently packed into bony voids or gaps of the skeletal system (i.e., the extremities, posterolateral spine and pelvis). These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. The product provides a bone void filler that resorbs and is replaced by the growth of new bone during the healing process. In weight bearing situations, the graft is to be used in conjunction with internal or external fixation devices. The fracture defect treated should not exceed 30 ml. Bi-Ostetic Foam Putty BERKELEY ADVANCED BIOMATERIALS, LLC
31 00816125023820 BF-02P BF-02P Bi-Ostetic Foam Putty is a sterile bone graft composed of purified fibrillar Typ Bi-Ostetic Foam Putty is a sterile bone graft composed of purified fibrillar Type I collagen and Bi-Ostetic (60% hydroxyapatite - 40% tricalcium phosphate) resorbable granules. This device is safe and has excellent biocompatibility. After it is implanted, the graft resorbs and is later replaced by natural bone.Bi-Ostetic Foam Putty is indicated for use in bony voids or gaps that are not intrinsic to the stability of the bony structure. The product should be gently packed into bony voids or gaps of the skeletal system (i.e., the extremities, posterolateral spine and pelvis). These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. The product provides a bone void filler that resorbs and is replaced by the growth of new bone during the healing process. In weight bearing situations, the graft is to be used in conjunction with internal or external fixation devices. The fracture defect treated should not exceed 30 ml. Bi-Ostetic Foam Putty BERKELEY ADVANCED BIOMATERIALS, LLC
32 00816125023813 BF-01P BF-01P Bi-Ostetic Foam Putty is a sterile bone graft composed of purified fibrillar Typ Bi-Ostetic Foam Putty is a sterile bone graft composed of purified fibrillar Type I collagen and Bi-Ostetic (60% hydroxyapatite - 40% tricalcium phosphate) resorbable granules. This device is safe and has excellent biocompatibility. After it is implanted, the graft resorbs and is later replaced by natural bone.Bi-Ostetic Foam Putty is indicated for use in bony voids or gaps that are not intrinsic to the stability of the bony structure. The product should be gently packed into bony voids or gaps of the skeletal system (i.e., the extremities, posterolateral spine and pelvis). These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. The product provides a bone void filler that resorbs and is replaced by the growth of new bone during the healing process. In weight bearing situations, the graft is to be used in conjunction with internal or external fixation devices. The fracture defect treated should not exceed 30 ml. Bi-Ostetic Foam Putty BERKELEY ADVANCED BIOMATERIALS, LLC
33 00816125023806 AA-10P AA-10P Bi-Ostetic Bioactive Glass Foam is a bone void filler consisting of a collagen m Bi-Ostetic Bioactive Glass Foam is a bone void filler consisting of a collagen matrix mineralized with hydroxyapatite (HA) – tri-calcium phosphate (TCP) granules and 45S5 bioactive glass granules. The bovine fibrillar collagen component is biocompatible and the 45S5 glass particles are bioactive.Bi-Ostetic Bioactive Glass Foam is indicated for use in bony voids or gaps of the skeletal system (i.e. extremities, pelvis and posterolateral spine). These osseous defects are surgically created or result from traumatic injury to the bone and are not intrinsic to the stability of the bony structure. The graft resorbs and is replaced by the growth of new bone during the healing process. Bi-Ostetic Bioactive Glass Foam must be used with autogenous bone marrow aspirate and autograft in the posterolateral spine. Bi-Ostetic Bioactive Glass Foam BERKELEY ADVANCED BIOMATERIALS, LLC
34 00816125023790 AA-05P AA-05P Bi-Ostetic Bioactive Glass Foam is a bone void filler consisting of a collagen m Bi-Ostetic Bioactive Glass Foam is a bone void filler consisting of a collagen matrix mineralized with hydroxyapatite (HA) – tri-calcium phosphate (TCP) granules and 45S5 bioactive glass granules. The bovine fibrillar collagen component is biocompatible and the 45S5 glass particles are bioactive.Bi-Ostetic Bioactive Glass Foam is indicated for use in bony voids or gaps of the skeletal system (i.e. extremities, pelvis and posterolateral spine). These osseous defects are surgically created or result from traumatic injury to the bone and are not intrinsic to the stability of the bony structure. The graft resorbs and is replaced by the growth of new bone during the healing process. Bi-Ostetic Bioactive Glass Foam must be used with autogenous bone marrow aspirate and autograft in the posterolateral spine. Bi-Ostetic Bioactive Glass Foam BERKELEY ADVANCED BIOMATERIALS, LLC
35 00816125023783 AA-01P AA-01P Bi-Ostetic Bioactive Glass Foam is a bone void filler consisting of a collagen m Bi-Ostetic Bioactive Glass Foam is a bone void filler consisting of a collagen matrix mineralized with hydroxyapatite (HA) – tri-calcium phosphate (TCP) granules and 45S5 bioactive glass granules. The bovine fibrillar collagen component is biocompatible and the 45S5 glass particles are bioactive.Bi-Ostetic Bioactive Glass Foam is indicated for use in bony voids or gaps of the skeletal system (i.e. extremities, pelvis and posterolateral spine). These osseous defects are surgically created or result from traumatic injury to the bone and are not intrinsic to the stability of the bony structure. The graft resorbs and is replaced by the growth of new bone during the healing process. Bi-Ostetic Bioactive Glass Foam must be used with autogenous bone marrow aspirate and autograft in the posterolateral spine. Bi-Ostetic Bioactive Glass Foam BERKELEY ADVANCED BIOMATERIALS, LLC
36 00816125023776 C10 SWE12 C10 SWE12 Tribio® DP Wedge is a bone void filler consisting of 60% hydroxyapatite (HA) and Tribio® DP Wedge is a bone void filler consisting of 60% hydroxyapatite (HA) and 40% beta-tri-calcium phosphate (TCP). These materials have been the topic of extensive clinical studies for several decades. The device provides a scaffold around which new bone can grow. A series of surface reactions on the particles results in the formation of a calcium phosphate layer that is substantially equivalent in composition and structure to the hydroxyapatite found in bone mineral. After implantation, the device resorbs and is later replaced by natural bone. Tribio® DP Evans Wedge BERKELEY ADVANCED BIOMATERIALS, LLC
37 00816125023769 C10 SWE10 C10 SWE10 Tribio® DP Wedge is a bone void filler consisting of 60% hydroxyapatite (HA) and Tribio® DP Wedge is a bone void filler consisting of 60% hydroxyapatite (HA) and 40% beta-tri-calcium phosphate (TCP). These materials have been the topic of extensive clinical studies for several decades. The device provides a scaffold around which new bone can grow. A series of surface reactions on the particles results in the formation of a calcium phosphate layer that is substantially equivalent in composition and structure to the hydroxyapatite found in bone mineral. After implantation, the device resorbs and is later replaced by natural bone. Tribio® DP Evans Wedge BERKELEY ADVANCED BIOMATERIALS, LLC
38 00816125023752 C10 SWE08 C10 SWE08 Tribio® DP Wedge is a bone void filler consisting of 60% hydroxyapatite (HA) and Tribio® DP Wedge is a bone void filler consisting of 60% hydroxyapatite (HA) and 40% beta-tri-calcium phosphate (TCP). These materials have been the topic of extensive clinical studies for several decades. The device provides a scaffold around which new bone can grow. A series of surface reactions on the particles results in the formation of a calcium phosphate layer that is substantially equivalent in composition and structure to the hydroxyapatite found in bone mineral. After implantation, the device resorbs and is later replaced by natural bone. Tribio® DP Evans Wedge BERKELEY ADVANCED BIOMATERIALS, LLC
39 00816125023745 C10 SWE06 C10 SWE06 Tribio® DP Wedge is a bone void filler consisting of 60% hydroxyapatite (HA) and Tribio® DP Wedge is a bone void filler consisting of 60% hydroxyapatite (HA) and 40% beta-tri-calcium phosphate (TCP). These materials have been the topic of extensive clinical studies for several decades. The device provides a scaffold around which new bone can grow. A series of surface reactions on the particles results in the formation of a calcium phosphate layer that is substantially equivalent in composition and structure to the hydroxyapatite found in bone mineral. After implantation, the device resorbs and is later replaced by natural bone. Tribio® DP Evans Wedge BERKELEY ADVANCED BIOMATERIALS, LLC
40 00816125023738 C10 SWC08 C10 SWC08 Tribio® DP Wedge is a bone void filler consisting of 60% hydroxyapatite (HA) and Tribio® DP Wedge is a bone void filler consisting of 60% hydroxyapatite (HA) and 40% beta-tri-calcium phosphate (TCP). These materials have been the topic of extensive clinical studies for several decades. The device provides a scaffold around which new bone can grow. A series of surface reactions on the particles results in the formation of a calcium phosphate layer that is substantially equivalent in composition and structure to the hydroxyapatite found in bone mineral. After implantation, the device resorbs and is later replaced by natural bone. Tribio® DP Cotton Wedge BERKELEY ADVANCED BIOMATERIALS, LLC
41 00816125023721 C10 SWC07 C10 SWC07 Tribio® DP Wedge is a bone void filler consisting of 60% hydroxyapatite (HA) and Tribio® DP Wedge is a bone void filler consisting of 60% hydroxyapatite (HA) and 40% beta-tri-calcium phosphate (TCP). These materials have been the topic of extensive clinical studies for several decades. The device provides a scaffold around which new bone can grow. A series of surface reactions on the particles results in the formation of a calcium phosphate layer that is substantially equivalent in composition and structure to the hydroxyapatite found in bone mineral. After implantation, the device resorbs and is later replaced by natural bone. Tribio® DP Cotton Wedge BERKELEY ADVANCED BIOMATERIALS, LLC
42 00816125023714 C10 SWC06 C10 SWC06 Tribio® DP Wedge is a bone void filler consisting of 60% hydroxyapatite (HA) and Tribio® DP Wedge is a bone void filler consisting of 60% hydroxyapatite (HA) and 40% beta-tri-calcium phosphate (TCP). These materials have been the topic of extensive clinical studies for several decades. The device provides a scaffold around which new bone can grow. A series of surface reactions on the particles results in the formation of a calcium phosphate layer that is substantially equivalent in composition and structure to the hydroxyapatite found in bone mineral. After implantation, the device resorbs and is later replaced by natural bone. Tribio® DP Cotton Wedge BERKELEY ADVANCED BIOMATERIALS, LLC
43 00816125023707 C10 SWC05 C10 SWC05 Tribio® DP Wedge is a bone void filler consisting of 60% hydroxyapatite (HA) and Tribio® DP Wedge is a bone void filler consisting of 60% hydroxyapatite (HA) and 40% beta-tri-calcium phosphate (TCP). These materials have been the topic of extensive clinical studies for several decades. The device provides a scaffold around which new bone can grow. A series of surface reactions on the particles results in the formation of a calcium phosphate layer that is substantially equivalent in composition and structure to the hydroxyapatite found in bone mineral. After implantation, the device resorbs and is later replaced by natural bone. Tribio® DP Cotton Wedge BERKELEY ADVANCED BIOMATERIALS, LLC
44 00816125023691 AMWS-TCP-BA-12 AMWS-TCP-BA-12 HA-TCP-Bioglass Sponge is a bone void filler consisting of a collagen matrix min HA-TCP-Bioglass Sponge is a bone void filler consisting of a collagen matrix mineralized with hydroxyapatite (HA) – tri-calcium phosphate (TCP) granules and 45S5 bioactive glass granules. The bovine fibrillar collagen component is biocompatible and the 45S5 glass particles are bioactive.HA-TCP-Bioglass Sponge is indicated for use in bony voids or gaps of the skeletal system (i.e. extremities, pelvis and posterolateral spine). These osseous defects are surgically created or result from traumatic injury to the bone and are not intrinsic to the stability of the bony structure. The graft resorbs and is replaced by the growth of new bone during the healing process. HA-TCP-Bioglass Sponge must be used with autogenous bone marrow aspirate and autograft in the posterolateral spine. HA-TCP-Bioglass Sponge BERKELEY ADVANCED BIOMATERIALS, LLC
45 00816125023684 AMWS-TCP-10 AMWS-TCP-10 HA-TCP Sponge is a sterile bone graft composed of purified fibrillar Type I coll HA-TCP Sponge is a sterile bone graft composed of purified fibrillar Type I collagen and Bi-Ostetic (60% hydroxyapatite - 40% tricalcium phosphate) resorbable granules. This device is safe and has excellent biocompatibility. After it is implanted, the graft resorbs and is later replaced by natural bone.HA-TCP Sponge is indicated for use in bony voids or gaps that are not intrinsic to the stability of the bony structure. The product should be gently packed into bony voids or gaps of the skeletal system (i.e., the extremities, posterolateral spine and pelvis). These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone. The product provides a bone void filler that resorbs and is replaced by the growth of new bone during the healing process. In weight bearing situations, the graft is to be used in conjunction with internal or external fixation devices. The fracture defect treated should not exceed 30 ml. HA-TCP Sponge BERKELEY ADVANCED BIOMATERIALS, LLC
46 00816125023677 OB-10D OB-10D OsteoBoost Select is a bio-engineered mixture of calcium-based inorganic compoun OsteoBoost Select is a bio-engineered mixture of calcium-based inorganic compounds. After it is implanted, OsteoBoost Select resorbs and is later replaced by natural bone. It provides a safe alternative to human or animal cadaver bone that completely eliminates the potential for disease transmission.OsteoBoost Select is an osteoconductive putty that is intended to be used to fill voids and gaps that are not intrinsic to the stability of the bone structure. These gaps or voids may be located in the extremities, spine, pelvis, or cranium.The putty may be shaped and pressed into the void by hand or inserted into a syringe and injected into the surgical site. The paste set in situ or ex situ provides a void filler that can augment hardware to support bone fragments during the surgical procedure. The set putty acts as a temporary support medium and is not intended to provide structural support during the healing process. The implant is radio-opaque. It is biocompatible and resorbs in the body as bone in-growth occurs. OsteoBoost Select 10cc BERKELEY ADVANCED BIOMATERIALS, LLC
47 00816125023660 OB-05D OB-05D OsteoBoost Select is a bio-engineered mixture of calcium-based inorganic compoun OsteoBoost Select is a bio-engineered mixture of calcium-based inorganic compounds. After it is implanted, OsteoBoost Select resorbs and is later replaced by natural bone. It provides a safe alternative to human or animal cadaver bone that completely eliminates the potential for disease transmission.OsteoBoost Select is an osteoconductive putty that is intended to be used to fill voids and gaps that are not intrinsic to the stability of the bone structure. These gaps or voids may be located in the extremities, spine, pelvis, or cranium.The putty may be shaped and pressed into the void by hand or inserted into a syringe and injected into the surgical site. The paste set in situ or ex situ provides a void filler that can augment hardware to support bone fragments during the surgical procedure. The set putty acts as a temporary support medium and is not intended to provide structural support during the healing process. The implant is radio-opaque. It is biocompatible and resorbs in the body as bone in-growth occurs. OsteoBoost Select 5cc BERKELEY ADVANCED BIOMATERIALS, LLC
48 00816125023653 M80 SB008 M80 SB008 Tribio™ Implant is a bone void filler consisting of a collagen matrix mineralize Tribio™ Implant is a bone void filler consisting of a collagen matrix mineralized with hydroxyapatite (HA) – tri-calcium phosphate (TCP) granules and 45S5 bioactive glass granules. The bovine fibrillar collagen component is biocompatible. The 45S5 glass particles are bioactive. The device is available in the form of granules, strips, and putty. The composition of the granules is 60 wt% HA and 40 wt% TCP. The amount of 45S5 granules in the graft is 20 wt%. The device provides a scaffold around which new bone can grow. A series of surface reactions on the particles results in the formation of a calcium phosphate layer that is substantially equivalent in composition and structure to the hydroxyapatite found in bone mineral. This apatite layer on the 45S5 granules and hydroxyapatite-tri-calcium phosphate granules provide an osteoconductive scaffold onto which the patient’s new bone will grow. During healing, the graft particulate is absorbed and remodeled into new bone. Tribio™ Implant, 7.5mm x 40mm BERKELEY ADVANCED BIOMATERIALS, LLC
49 00816125023646 M80 SB006 M80 SB006 Tribio™ Implant is a bone void filler consisting of a collagen matrix mineralize Tribio™ Implant is a bone void filler consisting of a collagen matrix mineralized with hydroxyapatite (HA) – tri-calcium phosphate (TCP) granules and 45S5 bioactive glass granules. The bovine fibrillar collagen component is biocompatible. The 45S5 glass particles are bioactive. The device is available in the form of granules, strips, and putty. The composition of the granules is 60 wt% HA and 40 wt% TCP. The amount of 45S5 granules in the graft is 20 wt%. The device provides a scaffold around which new bone can grow. A series of surface reactions on the particles results in the formation of a calcium phosphate layer that is substantially equivalent in composition and structure to the hydroxyapatite found in bone mineral. This apatite layer on the 45S5 granules and hydroxyapatite-tri-calcium phosphate granules provide an osteoconductive scaffold onto which the patient’s new bone will grow. During healing, the graft particulate is absorbed and remodeled into new bone. Tribio™ Implant, 5.5mm x 40mm BERKELEY ADVANCED BIOMATERIALS, LLC
50 00816125023639 AA1-100X25-12 AA1-100X25-12 Bi-Ostetic Bioactive Glass Foam is a bone void filler consisting of a collagen m Bi-Ostetic Bioactive Glass Foam is a bone void filler consisting of a collagen matrix mineralized with hydroxyapatite (HA) – tri-calcium phosphate (TCP) granules and 45S5 bioactive glass granules. The bovine fibrillar collagen component is biocompatible and the 45S5 glass particles are bioactive.Bi-Ostetic Bioactive Glass Foam is indicated for use in bony voids or gaps of the skeletal system (i.e. extremities, pelvis and posterolateral spine). These osseous defects are surgically created or result from traumatic injury to the bone and are not intrinsic to the stability of the bony structure. The graft resorbs and is replaced by the growth of new bone during the healing process. Bi-Ostetic Bioactive Glass Foam must be used with autogenous bone marrow aspirate and autograft in the posterolateral spine. Bi-Ostetic Bioactive Glass Foam BERKELEY ADVANCED BIOMATERIALS, LLC